IndusInd Bank terminates the agreement to acquire stakes in IL&FS Sec and ISSL, while the newly appointed board of IL&FS invites Expression of Interest from new bidders.

SEBI (Securities and Exchange Board of India) may further tighten norms to reduce the risks involved in liquid mutual funds. Read on to find out more.

After witnessing a sharp decline in the preceding month (September), mutual fund inflows stabilised in the month of October.

Following stocks are close to their 52-week low as at 1.11 p.m. on November 13, 2018.

InvaGen Pharmaceuticals, a subsidiary of pharma major Cipla, is set to acquire Avenue Therapeutics, a NASDAQ listed pharmaceutical company. The shares of Cipla, however, were trading marginally down at 0.54 per cent in the morning trading session.

The markets on November 13, 2018 opened gap down. BSE Sensex is trading at 34,872.89, up by 59.90 points and the Nifty is trading at 10,505.45, up by 23.25 points. 

The company's premium range of cars, which contribute majorly to its revenues, registered a 6 per cent YoY growth in October 2018, said a company release reporting Tata Motor's global wholesale figures.

Overall volumes in futures & options currently stand at 1.00 crore contracts with a turnover of Rs. 5,71,569.46 crore.

Overall volumes in futures & options currently stand at 1.00 crore contracts with a turnover of Rs. 5,71,569.46 crore.

Going ahead, there is a high probability of the weakness persisting in the index. Immediate support for the index is placed in the region of 10,442-10,458 which is the gap area formed on November 2. Stocks in news: HCL Technologies, NBCC, Lupin, TVS Motor, Aurobindo Pharma, Piramal Enterprises and Tata Motors.